These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 20155999)

  • 1. Spotlight on cerebrolysin in dementia.
    Plosker GL; Gauthier S
    CNS Drugs; 2010 Mar; 24(3):263-6. PubMed ID: 20155999
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cerebrolysin: a review of its use in dementia.
    Plosker GL; Gauthier S
    Drugs Aging; 2009; 26(11):893-915. PubMed ID: 19848437
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety profile of Cerebrolysin: clinical experience from dementia and stroke trials.
    Thome J; Doppler E
    Drugs Today (Barc); 2012 Apr; 48 Suppl A():63-9. PubMed ID: 22514795
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cerebrolysin improves symptoms and delays progression in patients with Alzheimer's disease and vascular dementia.
    Allegri RF; Guekht A
    Drugs Today (Barc); 2012 Apr; 48 Suppl A():25-41. PubMed ID: 22514793
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cerebrolysin for vascular dementia.
    Chen N; Yang M; Guo J; Zhou M; Zhu C; He L
    Cochrane Database Syst Rev; 2013 Jan; (1):CD008900. PubMed ID: 23440834
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cerebrolysin in mild-to-moderate Alzheimer's disease: a meta-analysis of randomized controlled clinical trials.
    Gauthier S; Proaño JV; Jia J; Froelich L; Vester JC; Doppler E
    Dement Geriatr Cogn Disord; 2015; 39(5-6):332-47. PubMed ID: 25832905
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cerebrolysin in vascular dementia: improvement of clinical outcome in a randomized, double-blind, placebo-controlled multicenter trial.
    Guekht AB; Moessler H; Novak PH; Gusev EI;
    J Stroke Cerebrovasc Dis; 2011; 20(4):310-8. PubMed ID: 20656516
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cerebrolysin enhances cognitive recovery of mild traumatic brain injury patients: double-blind, placebo-controlled, randomized study.
    Chen CC; Wei ST; Tsaia SC; Chen XX; Cho DY
    Br J Neurosurg; 2013 Dec; 27(6):803-7. PubMed ID: 23656173
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety and efficacy of Cerebrolysin in early post-stroke recovery: a meta-analysis of nine randomized clinical trials.
    Bornstein NM; Guekht A; Vester J; Heiss WD; Gusev E; Hömberg V; Rahlfs VW; Bajenaru O; Popescu BO; Muresanu D
    Neurol Sci; 2018 Apr; 39(4):629-640. PubMed ID: 29248999
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cerebrolysin in Alzheimer's disease: a randomized, double-blind, placebo-controlled trial with a neurotrophic agent.
    Panisset M; Gauthier S; Moessler H; Windisch M;
    J Neural Transm (Vienna); 2002 Jul; 109(7-8):1089-104. PubMed ID: 12111446
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cerebrolysin in Alzheimer's disease.
    Antón Álvarez X; Fuentes P
    Drugs Today (Barc); 2011 Jul; 47(7):487-513. PubMed ID: 22013558
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuroprotective treatment with cerebrolysin in patients with acute stroke: a randomised controlled trial.
    Ladurner G; Kalvach P; Moessler H;
    J Neural Transm (Vienna); 2005 Mar; 112(3):415-28. PubMed ID: 15583955
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combination treatment in Alzheimer's disease: results of a randomized, controlled trial with cerebrolysin and donepezil.
    Alvarez XA; Cacabelos R; Sampedro C; Couceiro V; Aleixandre M; Vargas M; Linares C; Granizo E; García-Fantini M; Baurecht W; Doppler E; Moessler H
    Curr Alzheimer Res; 2011 Aug; 8(5):583-91. PubMed ID: 21679156
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A prospective, randomized, placebo-controlled, double-blind trial about safety and efficacy of combined treatment with alteplase (rt-PA) and Cerebrolysin in acute ischaemic hemispheric stroke.
    Lang W; Stadler CH; Poljakovic Z; Fleet D;
    Int J Stroke; 2013 Feb; 8(2):95-104. PubMed ID: 23009193
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cerebrolysin for acute ischaemic stroke.
    Ziganshina LE; Abakumova T; Vernay L
    Cochrane Database Syst Rev; 2017 Apr; 4(4):CD007026. PubMed ID: 28430363
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Donepezil for vascular cognitive impairment.
    Malouf R; Birks J
    Cochrane Database Syst Rev; 2004; (1):CD004395. PubMed ID: 14974068
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety and efficacy of Cerebrolysin in motor function recovery after stroke: a meta-analysis of the CARS trials.
    Guekht A; Vester J; Heiss WD; Gusev E; Hoemberg V; Rahlfs VW; Bajenaru O; Popescu BO; Doppler E; Winter S; Moessler H; Muresanu D
    Neurol Sci; 2017 Oct; 38(10):1761-1769. PubMed ID: 28707130
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Randomized, placebo-controlled, double-blind, pilot trial to investigate safety and efficacy of Cerebrolysin in patients with aneurysmal subarachnoid hemorrhage.
    Woo PYM; Ho JWK; Ko NMW; Li RPT; Jian L; Chu ACH; Kwan MCL; Chan Y; Wong AKS; Wong HT; Chan KY; Kwok JCK
    BMC Neurol; 2020 Nov; 20(1):401. PubMed ID: 33143640
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cerebrolysin and early neurorehabilitation in patients with acute ischemic stroke: a prospective, randomized, placebo-controlled clinical study.
    Stan A; Birle C; Blesneag A; Iancu M
    J Med Life; 2017; 10(4):216-222. PubMed ID: 29362596
    [No Abstract]   [Full Text] [Related]  

  • 20. [Cerebrolysin for acute ischemic stroke].
    iganshina LE; Abakumova TR
    Vestn Ross Akad Med Nauk; 2013; (1):21-9. PubMed ID: 23805635
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.